Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Cerecor Inc. CERC
$2.93
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
38629413.00000000
-
week52high
4.50
-
week52low
1.98
-
Revenue
-
P/E TTM
-
Beta
1.44055900
-
EPS
-0.86700000
-
Last Dividend
0.00000000
-
Next Earnings Date
02 авг 2021 г. в 04:00
Описание компании
Cerecor Inc., a biopharmaceutical company, focuses on development and commercialization of treatments for rare pediatric and orphan diseases. It develop therapies for the treatment of inherited metabolic disorders, such as CERC-801 and CERC-802, which completed the phase I clinical trial; and CERC-803. The company is also involved in the developing of CERC-007, an anti-IL-18 monoclonal antibody for the treatment of autoimmune inflammatory diseases, such as adult onset stills disease and multiple myeloma; CERC-006, a dual mTOR inhibitor to treat complex lymphatic malformations; and CERC-002, an anti-LIGHT monoclonal antibody for the treatment of Pediatric-onset Crohn's diseases. In addition, it develops CERC-913, a protide nucleotide for the treatment of mitochondrial disorder; CERC-005, a monoclonal antibody to treat rare auto-inflammatory diseases; CERC-301 for the treatment of symptomatic Orthostatic Hypotension; and CERC-406 for the treatment of Parkinson's disease. Further, the company offers Millipred, an oral prednisolone for the treatment of inflammatory conditions, such as arthritis, blood disorders, immune system disorders, skin and eye conditions, respiratory disorders, cancer, and severe allergies. The company was formerly known as Ceregen Corporation and changed its name to Cerecor Inc. in March 2011. Cerecor Inc. was founded in 2011 and is headquartered in Rockville, Maryland.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
Cantor Fitzgerald | Overweight | 04 июн 2021 г. | |
Maxim Group | Buy | Hold | 21 апр 2021 г. |
Jefferies | Buy | 20 апр 2021 г. | |
Oppenheimer | Outperform | Outperform | 13 мая 2020 г. |
H.C. Wainwright | Buy | 02 дек 2019 г. |
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
Sullivan Christopher Ryan | A | 25000 | 25000 | 05 окт 2022 г. |
NEIL GARRY ARTHUR | A | 75000 | 75000 | 05 окт 2022 г. |
Persson Magnus | A | 3747 | 3747 | 30 сент 2022 г. |
KAPLAN GILLA | A | 3080 | 3080 | 30 сент 2022 г. |
Almenoff June Sherie | A | 605 | 605 | 30 сент 2022 г. |
Almenoff June Sherie | A | 4338 | 4338 | 30 июн 2022 г. |
KAPLAN GILLA | A | 44115 | 44115 | 30 июн 2022 г. |
Persson Magnus | A | 26837 | 26837 | 30 июн 2022 г. |
Almenoff June Sherie | A | 40000 | 40000 | 14 июн 2022 г. |
Chan Mitchell | A | 40000 | 40000 | 14 июн 2022 г. |
Свежие комментарии
Свежие комментарии